Human endometrial transforming growth factor-α: A transmembrane, surface epithelial protein that transiently disappears during the midsecretory phase of the menstrual cycle

Journal of the Society for Gynecologic Investigation

Volumn 4, Issue 3, 1997, Pages 160-166

  Hansard, Lisa J ^b   Healy Gardner, Bridget E ^b   Drapkin, Annie T ^b   Bentley, Rex C ^b   McLachlan, John A ^b   Walmer, David K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Endometrium; Human; Luminal epithelium; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANTIBODY SPECIFICITY; BLOTTING, WESTERN; DOUBLE-BLIND METHOD; ENDOMETRIUM; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MENSTRUAL CYCLE; MOLECULAR WEIGHT; SECRETORY RATE; SOLUBILITY; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0030832577     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(97)00016-6     Document Type: Article

References (34)

1. Tabibzadeh S, Sun XZ. Cytokine expression in human endometrium throughout the menstrual cycle. Hum Reprod 1992;7: 1214-21.
2. Walmer DK, Wrona MA, Hughes CL, Nelson KG. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: Correlation with circulating estradiol and progesterone. Endocrinology 1992;131:1458-66.
3. Walmer DK, Padin CJ, Wrona MA, et al. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res 1995;55:1168-75.
4. Kapur S, Tamada H, Dey SK, Andrews GK. Expression of insulin-like growth factor-I (IGF-I) and its receptor in the periimplantation mouse uterus, and cell-specific regulation of IGF-I gene expression by estradiol and progesterone. Biol Reprod 1992;46:208-19.
5. Boehm KD, Daimon M, Gorodeski IG, Sheean LA, Utian WH, Ilan J. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol Reprod Dev 1990; 27:93-101.
6. Nelson KG, Takahashi T, Lee DC, et al. Transforming growth factor-alpha is a potential mediator of estrogen action in the mouse uterus. Endocrinology 1992;131:1657-64.
7. Paria BC, Das SK, Gupta A. Dey SK. Reversal of indomethacin-induced inhibition of implantation in the mouse by epidermal growth factor. Prostaglandins 1991;42:191-9.
8. Imai T, Kurachi H, Adachi K, et al. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium. Biol Reprod 1995;52:928-38.
9. Horowitz GM, Scott RT Jr, Drews MR, Navot D, Hofmann GE. Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast. J Clin Endocrinol Metab 1993;76:786-92.
10. Paria BC, Das SK, Huet-Hudson YM, Dey SK. Distribution of transforming growth factor alpha precursors in the mouse uterus during the periimplantation period and after steroid hormone treatments. Biol Reprod 1994;50:481-91.
11. Tamada H, Das SK, Andrews GK, Dey SK. Cell-type-specific expression of transforming growth factor-alpha in the mouse uterus during the peri-implantation period. Biol Reprod 1991; 45:365-72.
12. Chia CM, Winston RM, Handyside AH. EGF, TGF-alpha and EGFR expression in human preimplantation embryos. Development 1995;121:299-307.
13. Dart LL, Smith DM, Meyers CA, Sporn MB, Frolik CA. Transforming growth factors from a human tumor cell: Characterization of transforming growth factor beta and identification of high molecular weight transforming growth factor alpha. Biochemistry 1985;24:5925-31.
14. Ignotz RA, Kelly B, Davis RJ, Massague J. Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Proc Natl Acad Sci U S A 1986; 83:6307-11.
15. Estival A, Clerc P, Vaysse N, Tam JP, Clemente F. Decreased expression of transforming growth factor alpha during differentiation of human pancreatic cancer cells. Gastroenterology 1992; 103:1851-9.
16. Bringman TS, Lindquist PB, Derynk R. Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell 1987;48:429-40.
17. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
18. Martin L, Finn CA, Trinder G. Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: An autoradiographic study. J Endocrinol 1973;56:133-44.
19. Martin L, Das RM, Finn CA. The inhibition by progesterone of uterine epithelial proliferation in the mouse. J Endocrinol 1973; 57:549-54.
20. Bhavnani BR, Woolever CA. Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus. Steroids 1991;56:201-10.
21. Newbold RR, Bullock BC, McLachlan JA. Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis. Cancer Res 1990; 50:7677-81.
22. Herbst AL, Anderson D. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol [review]. Semin Surg Oncol 1990;6:343-6.
23. Newbold RR, McLachlan JA. Diethylstilbestrol associated defects in murine genital tract development. In: McLachlan JA, ed. Estrogens in the environment. New York: Elsevier Science Publishing Co., Inc., 1985:288.
24. Haney AF, Hammond CB, Soules MR, Creasman WT. Diethylstilbestrol-induced upper genital tract abnormalities. Fertil Steril 1979;31:142-6.
25. Huet-Hudson YM, Chakraborty C, De SK, Suzuki Y, Andrews GK, Dey SK. Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells. Mol Endocrinol 1990;4:510-23.
26. Yeh J, Osathanondh R, Villa-Komaroff L. Expression of messenger ribonucleic acid for epidermal growth factor receptor and its ligands, epidermal growth factor and transforming growth factor-alpha, in human first- and second-trimester fetal ovary and uterus. AmJ Obstet Gynecol 1993;168:1569-73.
27. Skinner MK, Coffey RJ Jr. Regulation of ovarian cell growth through the local production of transforming growth factor-alpha by theca cells. Endocrinology 1988;123:2632-8.
28. Kudlow JE, Bjorge JD. TGF alpha in normal physiology [review]. Semin Cancer Biol 1990;1:293-302.
29. Ciardiello F, Kim N, McGeady ML, et al. Expression of transforming growth factor alpha (TGF alpha) in breast cancer. Ann Oncol 1991;2:169-82.
30. Pandiella A, Massague J. Cleavage of the membrane precursor for transforming growth factor-alpha is a regulated process. Proc Natl Acad Sci U S A 1991;88:1726-30.
31. Bosenberg MW, Pandiella A, Massague J. Activated release of membrane-anchored TGF-alpha in the absence of cytosol. J Cell Biol 1993;122:95-101.
32. Kim GY, Besner GE, Steffen CL, et al. Purification of heparin-binding epidermal growth factor-like growth factor from pig uterine luminal flushings, and its production by endometrial tissues. Biol Reprod 1995;52:561-71.
33. Wiley LM, Wu JX, Harari I, Adamson ED. Epidermal growth factor receptor mRNA and protein increase after the four-cell preimplantation stage in murine development. Dev Biol 1992; 149:247-60.
34. Paria BC, Dey SK. Preimplantation embryo development in vitro: Cooperative interactions among embryos and role of growth factors. Proc Nad Acad Sci U S A 1990;87:4756-60.